MATINICUS PHARMA LIMITED - HODDESDON
Company Profile | Company Filings |
Overview
MATINICUS PHARMA LIMITED is a Private Limited Company from HODDESDON ENGLAND and has the status: Active.
MATINICUS PHARMA LIMITED was incorporated 2 years ago on 25/01/2022 and has the registered number: 13870213. The accounts status is DORMANT and accounts are next due on 31/10/2024.
MATINICUS PHARMA LIMITED was incorporated 2 years ago on 25/01/2022 and has the registered number: 13870213. The accounts status is DORMANT and accounts are next due on 31/10/2024.
MATINICUS PHARMA LIMITED - HODDESDON
This company is listed in the following categories:
74909 - Other professional, scientific and technical activities n.e.c.
74909 - Other professional, scientific and technical activities n.e.c.
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 1 | 31/01/2023 | 31/10/2024 |
Registered Office
1 TOWER HOUSE
HODDESDON
HERTFORDSHIRE
EN11 8UR
ENGLAND
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
24/01/2024 | 07/02/2025 |
Map
ENGLAND
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MR CARL WATSON RAUSCH | Oct 1948 | American | Director | 2022-08-08 | CURRENT |
DR. BRIAN ROBERT LEAKER | Sep 1954 | British | Director | 2022-01-25 | CURRENT |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Dr. Brian Robert Leaker | 2022-01-25 | 9/1954 | Hoddesdon Hertfordshire |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Mr Carl Watson Rausch | 2022-01-25 | 10/1948 | Hoddesdon Hertfordshire |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
MATINICUS PHARMA LIMITED - Dormant accounts - members and to registrar (filleted) 23.1 | 2023-10-26 | 31-01-2023 | £100 Cash £100 equity |